Pilar de la Rocha Mur, VP, Head of EMEA, Global Clinical Operations at BeOne Medicines, shared on LinkedIn:
“I’m really excited to be heading back to my home country, Spain, for the ESMO Congress.
Our presence here this year truly reflects our commitment to oncology with solid tumors becoming an increasingly important part of our story with a broad and differentiated portfolio.
I look forward to all the gatherings with our oncology investigators from around the world and to the BeOne’s Investigator Meeting that will be pivotal to gather first hand knowledge on how we work with our oncology partners.
What are you looking forward to at ESMO26?”
Other articles about ESMO26 and BeOne Medicines on OncoDaily.